miR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-β

被引:84
|
作者
Sun, Wei [1 ]
Shen, Wenwen [1 ]
Yang, Shuang [1 ]
Hu, Fen [1 ]
Li, Huihui [1 ]
Zhu, Tian-Hui [1 ]
机构
[1] Nankai Univ, Coll Med, Mol Genet Lab, Tianjin 300071, Peoples R China
基金
中国国家自然科学基金;
关键词
miR-142; miR-223; LMO2-L; LMO2-S; CEBP-beta; proliferation; TRANSCRIPTION FACTORS; GENE-EXPRESSION; NUCLEAR EXPORT; PROTEIN LMO2; C/EBP-ALPHA; MICRORNAS; LEUKEMIA; ONCOGENE; TRANSLOCATIONS; PROMOTER;
D O I
10.1038/cr.2010.134
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
miR-142 and miR-223 have been identified as hematopoietic specific microRNAs. miR-223 has crucial functions in myeloid lineage development. However, the function of miR-142 remains unclear. In this study, we found that both miR-142 and miR-223 attenuated the proliferation of hematopoietic cells, and that miR-223 up-regulated miR-142 expression through the LMO2-L/-S isoforms and CEBP-beta. miR-223 negatively regulated both LMO2-U-S isoforms and CEBP-beta post-transcriptionally, while CEBP-beta positively regulated the LMO2-L/-S isoforms and both of the LMO2-L/-S isoforms negatively regulated miR-142. These results reveal a novel miR-223-CEBP-beta-LMO2-miR-142 regulatory pathway, which has pivotal functions in hematopoiesis.
引用
收藏
页码:1158 / 1169
页数:12
相关论文
共 50 条
  • [31] Ischemic brain extract increases SDF-1 expression in astrocytes through the CXCR2/miR-223/miR-27b pathway
    Shin, Jin Hee
    Park, Young Mi
    Kim, Dong Hee
    Moon, Gyeong Joon
    Bang, Oh Young
    Ohn, Takbum
    Kim, Hyeon Ho
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2014, 1839 (09): : 826 - 836
  • [32] Knockdown of long non-coding RNA TP73-AS1 inhibits osteosarcoma cell proliferation and invasion through sponging miR-142
    Yang, Guangling
    Song, Ruipeng
    Wang, Limin
    Wu, Xuejian
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 103 : 1238 - 1245
  • [33] miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11
    Zhou, Keshu
    Feng, Xiaoyan
    Wang, Yanying
    Liu, Yanyan
    Tian, Long
    Zuo, Wenli
    Yi, Shuhua
    Wei, Xudong
    Song, Yongping
    Qiu, Lugui
    EXPERIMENTAL HEMATOLOGY, 2018, 58 : 27 - 34
  • [34] KNOCKOUT OF MIR-223 INDUCES BETA-CELL DYSFUNCTION THROUGH ACTIVATION OF THE FOXO1 SIGNALING PATHWAY
    Li, Yutian
    Peng, Jiangtong
    Deng, Shan
    Wang, Xiaohong
    Kuhel, David
    Cash, James
    Essandoh, Kobina
    Mu, Xingjiang
    Salem, Esam
    Hui, David
    Fan, Guo-Chang
    FASEB JOURNAL, 2017, 31
  • [35] Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/β-Catenin Signaling Pathway Activation
    Qu, Hongbo
    Zhu, Fang
    Dong, Huaying
    Hu, Xiongqiang
    Han, Mingli
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [36] MiR-223 Regulates Human Embryonic Stem Cell Differentiation by Targeting the IGF-1R/Akt Signaling Pathway
    Yu, Yan-Hui
    Zhang, Li
    Wu, Deng-Shu
    Zhang, Zheng
    Huang, Fang-Fang
    Zhang, Jian
    Chen, Xiao-Ping
    Liang, De-Sheng
    Zeng, Hui
    Chen, Fang-Ping
    PLOS ONE, 2013, 8 (11):
  • [37] miR-223/FBW7 axis regulates doxorubicin sensitivity through epithelial mesenchymal transition in non-small cell lung cancer
    Li, Renyuan
    Wu, Shengjun
    Chen, Xin
    Xu, Hongfei
    Teng, Peng
    Li, Weidong
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (06): : 2512 - 2524
  • [38] miR-124 and miR-142 enhance cisplatin sensitivity of non-small cell lung cancer cells through repressing autophagy via directly targeting SIRT1
    Song, Xiang
    Kong, Fanyi
    Zong, Zhenfeng
    Ren, Mingming
    Meng, Qingjun
    Li, Yanguang
    Sun, Zhen
    RSC ADVANCES, 2019, 9 (09) : 5234 - 5243
  • [40] A novel strategy to attenuate porcine reproductive and respiratory syndrome virus by inhibiting viral replication in the target pulmonary alveolar macrophages via hematopoietic-specific miR-142
    Shaoyuan Tan
    Weixin Wu
    Xinna Ge
    Yongning Zhang
    Jun Han
    Xin Guo
    Lei Zhou
    Hanchun Yang
    One Health Advances, 1 (1):